You need to know about this new software company!

Richard Hemming

New coverage on a software company you won't have heard of 

At Under the Radar Report we are always on the hunt for small companies with big potential. In this week's report we’re excited about a stock that’s one of the few specialist software companies that has yet to hit blue sky valuation levels. Yes, it’s truly Under the Radar!

Small_Cap_Stock.png

The company’s niche is in the growing business of health & safety as big companies look to outsource this increasingly complicated area. Because this stock has made a well-timed acquisition its profits are growing at stratospheric levels on high profit margins. It seems too good to be true? Find out in tomorrow’s report where we look in detail at its fundamentals. Join now to access this new stock to buy and start investing in Small Caps confidently. 

Gold vs Bitcoin. 

In this week's Small Cap report we also compare and contrast Gold vs Bitcoin, but a key point is that it’s not whether one is better than the other, but how you can hedge your portfolio with gold stocks that have tremendous amounts of operating leverage. It’s no accident that Northern Star Resources (NST) ranks as our second best performing stock having returned almost 1600% on the price we first recommended back in mid-2012.

Watch out for more gold coverage over the coming weeks

In the next two weeks our mining analyst Peter Chilton rakes over the fundamentals on a number of gold stocks that have been sold off following recent weakness in the US dollar gold price and an appreciating domestic currency. We look at what’s next for Bitcoin and Gold tomorrow and cover in detail gold stocks, which look great value after the sell off..

Research tip updates on long-term favourites

But wait, there’s more! We look at a couple of long-term favourites that have had recent spikes, Centrepoint Financial (CAF) up 31% yesterday and the med-tech Cyclopharm (CYC) which is looking to hit the giant US market at pace with its nuclear based diagnostic technology for pulmonary embolism. We run the ruler over another med-tech, ImpediMed (IPD), a buynowpaylater specialist, our friends at a Chinese based electric scooter manufacturer and another med-tech, Volpara Health (VHT) which announced an acquisition this week. 
 
There is a great deal going on Under the Radar. You can’t afford to miss out. Join now to access this week's report and start investing confidently in Small Caps. 

About the Author

Richard Hemming

Richard Hemming (r.hemming@undertheradarreport.com.au) is an independent analyst who edits www.undertheradarreport.com.au, which provides investment opportunities in Small Caps that you won’t get anywhere else.

Under the Radar Report is licensed to give general financial advice only (AFSL: 409518). The author does not own shares in any of the stocks mentioned.

Did you miss?

As Seen In